'Last chemotherapy' diaporamas de présentation

Harold J. Burstein, MD, PhD Dana-Farber Cancer Institute Harvard Medical School Boston, MA

Strategic use of available agents through multiple lines of therapy for advanced ER/PR-negative disease: A discussion of 9 Things to Know About Metastatic Breast Cancer Beyond 1 st Line Chemotherapy. Harold J. Burstein, MD, PhD Dana-Farber Cancer Institute Harvard Medical School Boston, MA.

682 views • 58 slides

Estimating costs of diagnosis and treatment for lung cancer using linked longitudinal data

395 views • 31 slides

Job code: Eribulin-EU2095 Date of prep: July 2011

551 views • 29 slides